Mantosh Kumar Satapathy | Pharmacology | Best Researcher Award

Published on 15/10/202515/10/2025 by World Top Scientists

Dr. Mantosh Kumar Satapathy | Pharmacology | Best Researcher Award

Mantosh Kumar Satapathy | Taipei Medical University | Taiwan

Dr. Mantosh Kumar Satapathy, Ph.D., is a distinguished biomedical scientist, biotechnologist, pharmacologist, and tissue engineer based at Taipei Medical University, Taiwan, with extensive international experience in pharmacology, biomedical engineering, and nanobiotechnology. He earned his Ph.D. in Biomedical Materials and Tissue Engineering from Taipei Medical University, following an M.Tech. in Industrial Biotechnology and a Bachelor of Pharmacy, establishing a strong foundation in translational medical research. Dr. Satapathy has held postdoctoral and research fellow positions at leading institutions, leading projects on advanced nanodrug delivery systems, stem cell therapeutics, tissue engineering, and nanoformulation design, while supervising molecular biology laboratories and mentoring junior researchers. His research contributions include the development of stimuli-responsive nanocomposite hydrogels for orthopedic and skin tissue regeneration, engineering of nanocurcumin-based formulations for targeted therapies, and investigations into gene regulation and drug repurposing in cancer and skin pathologies. He has published extensively in high-impact peer-reviewed journals, contributed to international book chapters, co-invented a U.S. patent, and presented his work at global scientific conferences. Dr. Satapathy’s work has been recognized with multiple Outstanding Postdoctoral Researcher awards, and he actively serves as a peer reviewer, reflecting his leadership in the scientific community. He is a life member of professional organizations, has completed specialized research training in molecular diagnostics and biotechnology, and continues to advance interdisciplinary research that bridges fundamental science and clinical application, demonstrating exceptional impact in biomedical innovation.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Banerjee, P., Satapathy, M., Mukhopahayay, A., & Das, P. (2014). Leaf extract mediated green synthesis of silver nanoparticles from widely available Indian plants: Synthesis, characterization, antimicrobial property and toxicity analysis. Bioresources and Bioprocessing, 1(1), 3.

2. Satapathy, M. K., Yen, T. L., Jan, J. S., Tang, R. D., Wang, J. Y., Taliyan, R., & Yang, C. H. (2021). Solid lipid nanoparticles (SLNs): An advanced drug delivery system targeting brain through BBB. Pharmaceutics, 13(8), 1183.

3. Satapathy, M. K., & Das, P. (2014). Optimization of crystal violet dye removal using novel soil-silver nanocomposite as nanoadsorbent using response surface methodology. Journal of Environmental Chemical Engineering, 2(1), 708–714.

4. Satapathy, M. K., Banerjee, P., & Das, P. (2015). Plant-mediated synthesis of silver-nanocomposite as novel effective azo dye adsorbent. Applied Nanoscience, 5(1), 1–9.

5. Satapathy, M. K., Nyambat, B., Chiang, C. W., Chen, C. H., Wong, P. C., Ho, P. H., … (2018). A gelatin hydrogel-containing nano-organic PEI–Ppy with a photothermal responsive effect for tissue engineering applications. Molecules, 23(6), 1256.

Lichun Zhao | Pharmacology | Best Researcher Award

Published on 19/08/202519/08/2025 by World Top Scientists

Prof. Dr. Lichun Zhao | Pharmacology | Best Researcher Award

Guizhou University of Traditional Chinese Medicine, China

Prof. Dr. Lichun Zhao is a distinguished researcher and academic leader specializing in trace elements, traditional medicine, and health development. He serves as a doctoral supervisor, director of research centers and laboratories, and executive editor in chief of Trace Elements and Health Research, while holding key leadership roles in national and regional scientific associations. Recognized with numerous prestigious honors, he has successfully led major national and international projects, secured innovative medicine approvals, and contributed to product development. His prolific output includes over two hundred publications, highly cited SCI papers, multiple monographs, patents, and software copyrights, reflecting both scientific innovation and practical application. He has also been honored with multiple science and technology awards, underscoring the impact of his research. Committed to advancing both scholarship and healthcare, Prof. Zhao exemplifies excellence in integrating academic research, innovation, and leadership, making him a highly influential figure in his field.

Professional Profile

Scopus Profile

Education

Prof. Dr. Lichun Zhao earned his Ph.D. in a field closely related to trace elements, medicine, and health sciences, building a solid academic foundation for his future research. Following his doctoral studies, he pursued postdoctoral training at Hong Kong Baptist University, where he broadened his expertise and gained valuable international research exposure. His educational journey reflects a strong emphasis on both traditional medicine and modern scientific approaches, allowing him to bridge classical knowledge with contemporary methodologies. By combining advanced laboratory techniques with deep understanding of traditional Chinese medicine, he has cultivated a unique academic profile that continues to drive his research innovations. His educational background not only prepared him for his roles in academia and research but also established his credentials as a mentor for doctoral students and an authoritative voice in integrating traditional practices with modern scientific frameworks.

Experience

Prof. Dr. Zhao has accumulated extensive academic and professional experience through his multiple leadership roles and active engagement in research. He serves as a doctoral supervisor, guiding and mentoring the next generation of researchers, while simultaneously holding positions as director of the Research Department and the Center for Trace Elements and Health Development at Guizhou University of Chinese Medicine. Beyond his university roles, he directs major laboratories in Guizhou and Guangxi, leading innovation in endangered medicinal resources. His editorial work as executive editor in chief of Trace Elements and Health Research further demonstrates his commitment to advancing scholarly communication. In addition, he actively contributes to national scientific development as a project evaluation expert for significant research foundations and technology awards. Through these experiences, Prof. Zhao has built a career that integrates research, leadership, and service, positioning him as both a pioneering scientist and an influential academic administrator.

Research Focus

The core of Prof. Dr. Zhao’s research lies in the intersection of trace elements, traditional Chinese medicine, and health development. His work emphasizes the exploration of medicinal resources, the development of innovative treatments, and the application of modern scientific tools such as big data and artificial intelligence to healthcare research. He has led numerous national and international projects aimed at advancing understanding of trace elements in human health, as well as developing standardized, evidence-based approaches to traditional medicine. A significant part of his focus is dedicated to the preservation and innovation of endangered medicinal materials, ensuring sustainable resources for future therapeutic use. His achievements include obtaining clinical approvals for new medicine, producing certified products, and publishing influential studies recognized globally. Prof. Zhao’s research is notable for its ability to combine ancient knowledge with modern technology, creating novel solutions that enhance healthcare outcomes and scientific advancement.

Award and Honor

Prof. Dr. Zhao has been widely recognized for his scientific excellence and leadership with numerous national and regional awards. He was the first to receive the prestigious National Youth Qihuang Scholar distinction and has been selected for Hong Kong’s “Excellent Talent Plan.” His honors include recognition as an Outstanding Scholar in Guangxi, a leader of high-level innovation teams, and a candidate in talent development initiatives such as the “Ten Hundred Thousand Talents Project.” He has also received the Guangxi Youth Science and Technology Award and multiple provincial science and technology prizes, including the Guangxi Science and Technology Progress Award and the Jilin Province Natural Science Award. His contributions have further been acknowledged through the China Industry-University-Research Cooperation Innovation Award. Collectively, these distinctions highlight not only his research excellence but also his role as an innovator and leader whose work has had profound impact in both academic and applied scientific fields.

Publications Top Notes

Title: The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer’s disease: Research progress and insights
Authors: Zhao Lichun et al.
Year: 2025
Title: Bacteriostatic activity and mechanism of minerals containing rubidium
Authors: Zhao Lichun et al.
Year: 2025
Title: Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery
Authors: Zhao Lichun et al.
Year: 2025
Citations: 3
Title: Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
Authors: Zhao Lichun et al.
Year: 2025
Citations: 13
Title: Interfacial Stabilization through MOF-Polymer Core-Shell Design: Ultraefficient, Stable and Recyclable Enzymatic Microreactors
Authors: Zhao Lichun et al.
Year: 2025
Title: Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
Authors: Zhao Lichun et al.
Year: 2024
Citations: 22

Conclusion

The reviewed publications of Prof. Dr. Lichun Zhao reflect a strong and diverse research portfolio spanning trace elements, traditional Chinese medicine, cancer biology, inflammatory diseases, and innovative material science applications. His works demonstrate both depth in exploring mechanisms of disease and breadth in applying interdisciplinary approaches to health solutions. The range of topics covered—from Alzheimer’s disease and rhinosinusitis to breast cancer and ulcerative colitis—highlights his ability to integrate traditional medicine knowledge with modern biomedical and technological advances. The citations already received for some of these recent studies, particularly in high-impact areas such as cancer research and therapeutic innovations, indicate growing recognition of his contributions within the scientific community. Overall, his research achievements showcase academic rigor, innovation, and practical significance, further strengthening his candidacy for recognition through prestigious research awards.

Sireen Abdulrahim Shilbayeh | Clinical Pharmacy | Best Researcher Award

Published on 22/07/202522/07/2025 by World Top Scientists

Prof. Sireen Abdulrahim Shilbayeh | Clinical Pharmacy | Best Researcher Award

Professor at Princess Nora University, Pharmacy College, Riyadh, Saudi Arabia

Professor Sireen Abdulrahim Shilbayeh is a distinguished academic in clinical pharmacy with over two decades of experience in teaching, research, and healthcare practice. She earned her Ph.D. in Clinical Pharmacy Practice from the University of Nottingham, UK, specializing in pharmaceutical and health outcomes research, particularly the meta-analysis of antiarrhythmic drug trials. Currently a professor at Princess Nourah University in Riyadh, Saudi Arabia, she has held several key academic and administrative roles, including department head and scientific committee member. Her core strengths include evidence-based clinical practice, curriculum development, and interprofessional collaboration. She has been recognized with multiple institutional awards for research excellence and productivity. Her scholarly contributions span clinical trials, systematic reviews, and pharmacy education, supported by active participation in international conferences. Professor Shilbayeh is committed to advancing pharmacy practice through impactful research, academic leadership, and the mentoring of future healthcare professionals.

Professional Profile

Google Scholar
Scopus Profile

Strengths for the Award

Professor Shilbayeh demonstrates a distinguished and consistent record of academic and research achievements. Her doctoral training from the University of Nottingham, UK, focused on high-impact, evidence-based clinical pharmacy research, particularly in meta-analysis and systematic reviews—areas that are fundamental to improving clinical decision-making and healthcare outcomes.

Her long-standing academic trajectory, progressing from Assistant to Full Professor, across multiple universities, reflects both resilience and recognition of her scholarly contributions. She has served in prestigious roles, including chair memberships in university scientific councils and IRB committees, indicating peer trust and leadership in research governance.

Further, she has received multiple awards for research excellence from Princess Nourah University, particularly for prolific output in health sciences—a strong testament to her research productivity and impact. Her work on antiarrhythmic drug evaluations and pharmacoepidemiology, combined with over two decades of conference participation, showcases her dedication to scientific dissemination and continuing professional development.

Education

Professor Sireen Abdulrahim Shilbayeh holds a strong academic foundation in pharmaceutical sciences. She began her studies at King Saud University in Riyadh, Saudi Arabia, where she earned her Bachelor’s degree in Pharmacy. Seeking to further her education, she pursued postgraduate studies at the University of Nottingham in the United Kingdom. There, she completed an MPhil in Clinical Pharmacy, focusing on systematic reviews of clinical trials, followed by a Ph.D. in Clinical Pharmacy Practice. Her doctoral research specialized in the meta-analysis of randomized clinical trials involving antiarrhythmic drugs, combining rigorous scientific methodology with practical clinical implications. Throughout her academic journey, she developed a comprehensive understanding of clinical pharmacy, pharmacoepidemiology, and pharmaceutical care. Her education has been instrumental in shaping her evidence-based research approach, teaching philosophy, and ability to lead complex projects in academia and healthcare. These qualifications have paved the way for her successful academic and professional career in the region and beyond.

Experience

Professor Shilbayeh brings over 25 years of academic and clinical experience in pharmacy. She began her professional career as a pharmacist at King Khaled University Hospital in Riyadh, gaining hands-on experience in inpatient and outpatient services, IV preparation, and drug information. She later worked as a clinical researcher at Nottingham University Hospital, focusing on cardiovascular pharmacotherapy. Her academic journey includes positions at Applied Science University and Al-Zytoonah University in Jordan, where she progressed from Assistant to Associate Professor. Since 2010, she has been affiliated with Princess Nourah University, where she became a Full Professor in 2015. Beyond teaching, she has served in several administrative capacities, including Head of the Clinical Pharmacy Practice Department, and as a member of the Institutional Review Board, Scientific Council, and Development Committees. Her career is marked by a blend of teaching excellence, research leadership, and a commitment to advancing clinical pharmacy education and healthcare practices.

🏅Awards and Honors

Professor Sireen Shilbayeh has received multiple accolades recognizing her contributions to research and academia. Among her most notable honors is the Excellence in Research Productivity Award from Princess Nourah University, awarded across all health-related faculties. This prestigious recognition highlights her extensive research output and impact within the healthcare sector. Additionally, she received an Appreciation Award from the University’s Graduate and Research Agency for her distinguished publications in indexed international journals. These awards reflect her dedication to scholarly excellence, continuous engagement with high-quality research, and leadership within the academic community. Her ability to maintain consistent output while supporting academic development and policy initiatives has earned her widespread respect. These honors also serve as acknowledgment of her commitment to raising standards in pharmacy practice and education, both regionally and internationally. Her achievements continue to inspire colleagues and students, solidifying her reputation as a leading figure in clinical pharmacy research.

Research Focus on Clinical Pharmacy

Professor Shilbayeh’s research centers on clinical pharmacy practice, with a strong emphasis on evidence-based medicine, pharmaceutical care, and health outcomes research. Her early work, including her doctoral dissertation, focused on the meta-analysis of antiarrhythmic drug trials, contributing valuable insights into cardiology-related pharmacotherapy. She is deeply involved in systematic reviews, pharmacoepidemiology, and comparative effectiveness research, ensuring her findings have direct clinical relevance. Her scholarly interests also span patient-centered care, drug safety, and therapeutic decision-making, aiming to improve the quality and efficiency of healthcare delivery. She frequently collaborates on projects addressing chronic disease management and clinical interventions in pharmacy practice. Through her work on the Institutional Review Board, she contributes to research ethics and the development of robust study designs. Her research not only informs clinical practice but also plays a key role in curriculum development and training for future pharmacists, emphasizing scientific rigor and real-world application.

Publications Top Notes

Title: Prevalence of osteoporosis and its reproductive risk factors among Jordanian women: a cross-sectional study
Authors: S. Shilbayeh
Year: 2003
Citations: 114
Title: Exploring knowledge and attitudes towards counselling about vitamin supplements in Jordanian community pharmacies
Authors: S.A. Shilbayeh
Year: 2011
Citations: 42
Title: Validation of knowledge and adherence assessment tools among patients on warfarin therapy in a Saudi hospital anticoagulant clinic
Authors: S.A.R. Shilbayeh, W.A. Almutairi, S.A. Alyahya, N.H. Alshammari, E. Shaheen, et al.
Year: 2018
Citations: 40
Title: University students’ knowledge, attitudes, and practices towards the national premarital screening program of Saudi Arabia
Authors: M. Melaibari, S. Shilbayeh, A. Kabli
Year: 2017
Citations: 35
Title: Does COVID-19 lockdowns have impacted on global dengue burden? A special focus to India
Authors: H. Sharma, A. Ilyas, A. Chowdhury, N.K. Poddar, A.A. Chaudhary, et al.
Year: 2022
Citations: 29
Title: The impact of CYP3A5 and MDR1 polymorphisms on tacrolimus dosage requirements and trough concentrations in pediatric renal transplant recipients
Authors: S. Shilbayeh, R. Zmeili, R.I. Almardini
Year: 2013
Citations: 22
Title: A Markov Chain Model to Evaluate the Effect of CYP3A5 and ABCB1 Polymorphisms on Adverse Events Associated with Tacrolimus in Pediatric Renal Patients
Authors: S.K.B. Sy, J. Heuberger, S. Shilbayeh, D.J. Conrado, H. Derendorf
Year: 2013
Citations: 19
Title: Pediatric renal transplantation in the Jordanian population: the clinical outcome measures during long-term follow-up period
Authors: S. Shilbayeh, I. Hazza
Year: 2012
Citations: 17
Title: Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment
Authors: S.A.R. Shilbayeh, S.K.B. Sy, M. Melhem, R. Zmeili, H. Derendorf
Year: 2015
Citations: 14
Title: Possible interethnic differences in omeprazole pharmacokinetics: comparison of Jordanian Arabs with other populations
Authors: S. Shilbayeh, M.F. Tutunji
Year: 2006
Citations: 14
Title: Treatment satisfaction questionnaire for medication: validation of the translated Arabic version among patients undergoing warfarin therapy in Saudi Arabia
Authors: S.A.R. Shilbayeh, S.A. Alyahya, N.H. Alshammari, W.A. Almutairi, E. Shaheen
Year: 2018
Citations: 10
Title: The impact of genetic polymorphisms on time required to attain the target tacrolimus levels and subsequent pharmacodynamic outcomes in pediatric kidney transplant patients
Authors: S. Shilbayeh
Year: 2014
Citations: 10
Title: Influence of CYP3A5 6986A > G and ABCB1 3435C > T Polymorphisms on Adverse Events Associated With Tacrolimus in Jordanian Pediatric Renal Patients
Authors: S.K.B. Sy, R.P. Singh, S. Shilbayeh, R. Zmeili, D. Conrado, H. Derendorf
Year: 2013
Citations: 9
Title: The anti-clot treatment scale (ACTS): validation of the translated Arabic version among patients undergoing warfarin therapy in Saudi Arabia
Authors: S.A.R. Shilbayeh, A.A. Ibrahim
Year: 2020
Citations: 7
Title: Patient experience with an educational mobile health application: A pilot study on usability and feasibility in a Saudi population
Authors: I.S.A. Shilbayeh, S.A. Shilbayeh
Year: 2020
Citations: 7

🏁 Conclusion

The Clinical Pharmacy Award is more than a recognition—it’s a platform to celebrate innovation, dedication, and impact in pharmaceutical care. By honoring professionals who excel in clinical practice, education, and research, this award promotes advancement in healthcare delivery and encourages the adoption of evidence-based, patient-centered approaches. Whether you’re an academic, clinician, or researcher, this is your opportunity to showcase your contributions to the evolving field of pharmacy. Apply now, inspire others, and join a distinguished network of leaders shaping the future of clinical pharmacy.

Dr. Christian Seebauer | Pharmacology | Best Researcher Award

Published on 14/07/202514/07/2025 by World Top Scientists

Dr. Christian Seebauer | Pharmacology | Best Researcher Award

Senior Consultant at Department of Oral and Maxillofacial Surgery / Plastic surgery, University Medicine Lübeck, Germany

Dr. med. Christian Seebauer, MD, DDS, is a distinguished clinician-scientist with dual qualifications in medicine and dentistry and board certifications in Oral and Maxillofacial Surgery and Oral Surgery. Currently a Senior Consultant at University Medical Center Lübeck, he has held several leadership roles in academic surgery. His research focuses on innovative therapies such as cold atmospheric plasma for cancer, wound healing, and oral diseases. He has authored impactful publications in high-ranking journals, with a strong emphasis on translational and interdisciplinary research. Awarded a summa cum laude for his medical doctorate, he is pursuing a second doctorate in dental medicine and a habilitation. Dr. Seebauer is actively involved in clinical trials, academic teaching, and scientific advising. His work reflects a commitment to advancing patient care through science, collaboration, and clinical excellence, making him a highly suitable candidate for prestigious research recognition such as the Best Researcher Award.

Professional Profile

Google Scholar
Scopus Profile

Education

Dr. Christian Seebauer’s educational background reflects his exceptional commitment to interdisciplinary medical science. He earned his medical degree from Friedrich-Schiller-University Jena in 2006, graduating with high distinction and obtaining his medical license with a “very good” grade. Driven by an interest in craniofacial care, he pursued a second degree in dentistry at Ernst-Moritz-Arndt-University Greifswald, earning his dental license in 2015, again with top marks. He completed specialist training in Oral and Maxillofacial Surgery (2020) and Oral Surgery (2021), and is on track to receive an additional qualification in Plastic and Aesthetic Surgery by 2025. Academically, he achieved his Doctor of Medicine (summa cum laude) from Charité – Berlin in 2012, is completing a second doctorate in dental medicine, and is preparing his habilitation at University Medical Center Lübeck. His dual training uniquely equips him for complex surgical, academic, and translational roles in modern healthcare.

Professional Experience

Dr. Seebauer has accumulated extensive clinical and academic experience in leading German medical institutions. He began his residency in musculoskeletal surgery at Charité – Berlin (2007–2010), then transitioned into Oral and Maxillofacial Surgery at University Medical Centers in Jena and Greifswald. At Greifswald, he steadily advanced from resident to Specialist, then Senior Consultant, and eventually Managing Senior Consultant by 2023. In August 2024, he was appointed Senior Consultant at the University Medical Center Lübeck. Throughout his career, he has taken on multiple responsibilities beyond patient care, including roles in transfusion medicine, radiation safety, and medical coding. Dr. Seebauer is experienced in running clinical trials, mentoring young surgeons, and integrating advanced surgical techniques such as microvascular tissue transfer and plasma-based therapies. His professional trajectory demonstrates continuous growth in clinical leadership, academic excellence, and institutional trust, confirming his status as a respected authority in surgical and translational medicine.

Research Interest

Dr. Seebauer’s research centers on innovative, translational approaches to oral, mucosal, and dermal disease management, with a particular emphasis on cold atmospheric plasma. His work spans a range of high-impact medical themes, including wound healing, cancer therapy, precancerous lesions, chronic inflammation, and alternative cancer treatments. He has contributed significantly to both preclinical and clinical investigations, exploring how plasma technologies can improve outcomes in head and neck cancer, oral lichen planus, and leukoplakia. His recent studies include cohort analyses on the effects of anticoagulants on wound healing and the global impact of HPV vaccination on malignancy risks. He is actively involved in the planning of prospective, multicenter clinical trials and collaborates internationally via networks like TriNetX. His multidisciplinary approach combines surgery, oncology, immunology, and biomedical engineering, showcasing his ability to merge clinical insight with experimental innovation. These interests place him at the forefront of translational medical research in Europe.

Award and Honor

Dr. Christian Seebauer has earned several distinctions throughout his academic and clinical career. He was awarded his Doctor of Medicine degree summa cum laude, one of the highest academic honors in Germany, by the prestigious Charité – University Medical Center Berlin. His scientific work has been published in internationally renowned, peer-reviewed journals such as Radiology, Oral Diseases, and Pharmacological Research, some with impact factors exceeding 10. He has held trusted leadership roles, including Managing Senior Consultant, and serves as a Scientific Advisor to neoplas MED. His selection for these positions reflects institutional recognition of his scientific and clinical integrity. Although not explicitly listed, his rising trajectory in academic medicine and involvement in high-level research projects suggest a strong reputation within professional circles. His affiliations with organizations such as the National Center for Plasma Medicine and Rotary Club also highlight his commitment to service and excellence beyond his clinical duties.

Conclusion

Dr. Christian Seebauer exemplifies the ideal candidate for recognition as a Best Researcher. With dual qualifications in medicine and dentistry, a track record of clinical leadership, and a deep commitment to translational research, he bridges the gap between scientific discovery and patient care. His pioneering work in cold atmospheric plasma and its applications in oncology and regenerative medicine is both innovative and impactful, reflecting future-forward thinking in clinical science. His publication record, leadership roles, and collaborative involvement in global research initiatives further establish his credibility and influence in the medical community. Dr. Seebauer’s academic path—marked by excellence, versatility, and continual advancement—underscores his dedication to improving healthcare through research, education, and clinical innovation. As he continues his habilitation and leads new clinical trials, his contributions are poised to shape future standards in surgery and therapeutic technology. He is highly deserving of prestigious accolades such as the Best Researcher Award.

Publications Top Notes

Title: Clinical experience with cold plasma in the treatment of locally advanced head and neck cancer
- Authors: HR Metelmann, C Seebauer, V Miller, A Fridman, G Bauer, DB Graves, …
- Year: 2018
- Citations: 353
Title: Head and neck cancer treatment and physical plasma
- Authors: HR Metelmann, DS Nedrelow, C Seebauer, M Schuster, T von Woedtke, …
- Year: 2015
- Citations: 256
Title: Molecular mechanisms of the efficacy of cold atmospheric pressure plasma (CAP) in cancer treatment
- Authors: ML Semmler, S Bekeschus, M Schäfer, T Bernhardt, T Fischer, K Witzke, …
- Year: 2020
- Citations: 216
Title: Comprehensive clinical plasma medicine: cold physical plasma for medical application
- Authors: HR Metelmann, T Von Woedtke, KD Weltmann
- Year: 2018
- Citations: 162
Title: Visible tumor surface response to physical plasma and apoptotic cell kill in head and neck cancer
- Authors: M Schuster, C Seebauer, R Rutkowski, A Hauschild, F Podmelle, …
- Year: 2016
- Citations: 152
Title: Cold atmospheric pressure plasma in wound healing and cancer treatment
- Authors: L Boeckmann, M Schäfer, T Bernhardt, ML Semmler, O Jung, G Ojak, …
- Year: 2020
- Citations: 100
Title: Treating cancer with cold physical plasma: On the way to evidence‐based medicine
- Authors: HR Metelmann, C Seebauer, R Rutkowski, M Schuster, S Bekeschus, …
- Year: 2018
- Citations: 65
Title: Hyperspectral imaging for in vivo monitoring of cold atmospheric plasma effects on microcirculation in treatment of head and neck cancer and wound healing
- Authors: R Rutkowski, M Schuster, J Unger, C Seebauer, HR Metelmann, …
- Year: 2017
- Citations: 58
Title: Ankle laxity: stress investigation under MRI control
- Authors: CJ Seebauer, HJ Bail, JC Rump, B Hamm, T Walter, UKM Teichgräber
- Year: 2013
- Citations: 55
Title: Side effects in cold plasma treatment of advanced oral cancer—Clinical data and biological interpretation
- Authors: M Schuster, R Rutkowski, A Hauschild, RK Shojaei, T von Woedtke, …
- Year: 2018
- Citations: 48
Title: Physical plasma and leukocytes–immune or reactive?
- Authors: S Bekeschus, C Seebauer, K Wende, A Schmidt
- Year: 2018
- Citations: 42
Title: Plasmamedizin
- Authors: HR Metelmann, T von Woedtke, KD Weltmann
- Year: 2016
- Citations: 42
Title: Cold argon plasma as adjuvant tumour therapy on progressive head and neck cancer: A preclinical study
- Authors: S Hasse, C Seebauer, K Wende, A Schmidt, HR Metelmann, …
- Year: 2019
- Citations: 41
Title: Third molars and periodontal damage of second molars in the general population
- Authors: S Kindler, B Holtfreter, T Koppe, M Mksoud, C Lucas, C Seebauer, …
- Year: 2018
- Citations: 36
Title: Plasma-derived reactive species shape a differentiation profile in human monocytes
- Authors: E Freund, J Moritz, M Stope, C Seebauer, A Schmidt, S Bekeschus
- Year: 2019
- Citations: 34

Mrs. fangyan He | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on 12/02/202512/02/2025 by World Top Scientists

Mrs. fangyan He | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Senior Experimentalist at Yunnan University of Traditional Chinese Medicine, China

He Fangyan is a distinguished researcher specializing in the pharmacodynamics and pharmacokinetics of traditional Chinese medicine. Currently serving as a Senior Experimentalist at Yunnan University of Traditional Chinese Medicine, she has led multiple high-impact studies focusing on ischemic stroke mechanisms and brain pharmacokinetics. With a commitment to advancing neuropharmacology, she has secured prestigious research grants, contributed to key scientific advancements, and developed innovative methodologies in cerebral ischemia treatment. Her expertise extends to drug metabolism, blood-brain barrier protection, and targeted drug delivery, making her a prominent figure in the field. Through her patents, publications, and ongoing research, she continues to bridge the gap between traditional Chinese medicine and modern pharmacological science.

Professional Profile

ORCID Profile

Education

He Fangyan holds an advanced degree in pharmacology and traditional Chinese medicine research, equipping her with interdisciplinary expertise in both experimental and clinical pharmacokinetics. She has undergone rigorous training in drug absorption, metabolism, and pharmacodynamics, particularly focusing on ischemic stroke therapies. Her academic background includes specialized studies in cerebral ischemia-reperfusion injury and neuroprotection, which laid the foundation for her innovative research contributions. She has further enhanced her knowledge through postgraduate research projects, technical training in pharmacological analysis, and collaborations with leading scientists in neurological drug development. Her education has provided her with a strong analytical and methodological foundation, enabling her to conduct cutting-edge research in traditional Chinese medicine’s role in stroke management.

Professional Experience

With extensive experience in experimental pharmacology and neuroscience, He Fangyan has held a senior research position at Yunnan University of Traditional Chinese Medicine, leading multiple research projects funded by national and provincial grants. She has played a pivotal role in advancing traditional Chinese medicine applications for stroke treatment, particularly through the study of Gastrodia’s neuroprotective effects. Over the years, she has worked on high-impact studies integrating brain microdialysis, PK/PD modeling, and oxidative stress mechanisms. In addition to academic research, she has contributed to methodology development in neuropharmacology, ensuring precise drug targeting and evaluation of traditional medicine compounds. Her professional contributions also extend to mentoring young researchers and fostering interdisciplinary collaborations, strengthening the field of pharmacokinetics and neuroprotection.

Research Interests

He Fangyan’s primary research interests revolve around cerebral ischemia, blood-brain barrier protection, and pharmacokinetics of traditional Chinese medicine compounds. She is particularly focused on understanding the mechanisms of ischemic stroke and the therapeutic potential of Gastrodia-derived compounds in treating oxidative stress-induced brain damage. Her studies employ microdialysis techniques, drug metabolism analysis, and neuroprotective compound development, making significant contributions to stroke research. She is also deeply invested in the translation of traditional Chinese medicine principles into modern pharmacological applications, aiming to bridge ancient remedies with contemporary scientific methodologies. Additionally, she explores novel drug delivery systems and prodrug mechanisms, ensuring targeted treatment with minimal side effects for cerebrovascular diseases.

Awards and Honors

He Fangyan has been recognized for her outstanding contributions to traditional Chinese medicine research and neuropharmacology. She has received funding from prestigious institutions such as the National Natural Science Foundation of China and the Yunnan Science and Technology Department, reflecting the significance of her work. Her patented innovations in cerebral ischemia treatment have earned acclaim, contributing to advancements in stroke therapy. She has also published extensively in SCI-indexed journals, further solidifying her academic reputation. As a key figure in pharmacokinetics and stroke research, she has been invited to speak at academic conferences and collaborate on national research initiatives. Her dedication to scientific progress and innovation continues to garner recognition, positioning her as a leading researcher in the field of traditional Chinese medicine and neuroscience.

Conclusion

He Fangyan is a strong candidate for the Best Researcher Award due to extensive contributions to pharmacokinetics and stroke research, significant grant funding, patents, and high-impact journal publications. Strengthening industry ties, international collaborations, and academic outreach could further solidify eligibility for top-tier research awards.

Publications Top Noted

He, F., Feng, J., Sun, H., Xu, Y., Yan, H., Song, X., Wang, Y., Li, X., & Lin, Q. (2024). Protective Effect of Protocatechuic Aldehyde on Cerebral Ischemia/Reperfusion Injury in Rats through Blood–Brain Barrier Protection. Bulletin of Experimental Biology and Medicine. https://doi.org/10.1007/s10517-024-06264-z
He, F., Xu, C., Feng, J., Sun, H., Yan, M., Yang, Q., Zhou, X., Yang, J., & Lin, Q. (2024). Pharmacokinetics of 4-Hydroxybenzaldehyde in Normal and Cerebral Ischemia–Reperfusion Injury Rats Based on Microdialysis Technique. European Journal of Drug Metabolism and Pharmacokinetics. https://doi.org/10.1007/s13318-023-00863-3
He, F., Ma, C., Feng, J., Li, X., Xia, S., Lin, Q., Dai, R., & He, F. (2021). Angiogenesis effects of 4-methoxy benzyl alcohol on cerebral ischemia-reperfusion injury via regulation of VEGF-Ang/Tie2 balance. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2021-0118
He, F., Dai, R., Zhou, X., Li, X., Song, X., Yan, H., Meng, Q., Yang, C., & Lin, Q. (2019). Protective effect of 4-Methoxy benzyl alcohol on the neurovascular unit after cerebral ischemia reperfusion injury. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2019.109260
He, F., Duan, X., Dai, R., Li, Y., & Lin, Q. (2017). Protective Effect of 4-Methoxy Benzyl Alcohol on the Blood–Brain Barrier after Cerebral Ischemia Reperfusion Injury. Journal of Stroke and Cerebrovascular Diseases. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.01.018

Samer Younes | Pharmacology | Best Researcher Award

Published on 25/08/202425/08/2024 by World Top Scientists

Dr. Samer Younes | Pharmacology | Best Researcher Award

Department of Pharmacy, Tartous University, Syria

🌟 Samer Younes is a dedicated and forward-thinking pharmacy graduate from Tartous University, Syria. With a strong academic background and diverse experience in both practical pharmacy and research, Samer is committed to continuous learning and professional development. His work ethic is demonstrated through his active participation in community volunteering, internships, and a keen interest in expanding his expertise in the field of pharmacy and nutrition.

Profile

Google Scholar

Research for “Best Researcher Award”

Strengths for the Award

1. Strong Academic Foundation and Practical Experience:
Samer Younes has demonstrated a solid academic foundation with a Bachelor’s degree in Pharmacy from Tartous University, complemented by practical experience in various pharmacy roles and internships. His work as a pharmacist involved crucial tasks such as prescription processing and handling patient queries, showcasing his applied knowledge in the field.

2. Commitment to Continuous Learning and Professional Development:
Samer’s commitment to professional growth is evident from his various certifications, including Quality Advisor and specialized training in Nutrition and Laboratory Work. These certifications not only add to his qualifications but also highlight his proactive approach to expanding his skill set and knowledge.

3. Volunteer Experience and Community Engagement:
His volunteer work with UNICEF and involvement in the Campaign against Covid-19 underline his dedication to societal well-being and public health. His role in these initiatives, including vaccinations and monitoring children’s rights, demonstrates his ability to apply his expertise in real-world scenarios and contribute to community health.

4. Language and Digital Skills:
Samer possesses proficiency in multiple languages, which enhances his ability to communicate and collaborate in diverse settings. His digital skills, including expertise in Microsoft Office and analytical tools, are essential for modern research and data analysis.

5. Strong Recommendations:
Samer has received commendations from reputable professors, such as Wissam Zam and Zeina Hamama, who can vouch for his academic prowess and research capabilities. Their recommendations add credibility to his achievements and potential as a researcher.

Areas for Improvement

1. Limited Research Publications:
While Samer has a commendable academic background and practical experience, his publication record appears limited. Expanding his research output and publishing in high-impact journals could enhance his visibility and influence in the field of pharmacy and research.

2. Focused Research Experience:
Although Samer has engaged in diverse roles and projects, a more focused research experience in specific areas of pharmacy or a related field could strengthen his application. Specializing in a niche area and contributing significant research could further solidify his candidacy for the award.

3. Networking and Collaboration:
Building a stronger professional network and engaging in collaborative research projects could provide additional opportunities for growth and recognition. Participating in conferences and research forums would also help him gain further exposure and feedback from the scientific community.

4. Enhanced Research Visibility:
Increasing his presence in research communities, such as ResearchGate and Google Scholar, by regularly updating his profiles and engaging with other researchers could improve his visibility and impact in the research domain.

Education

🎓 Bachelor Degree in Pharmacy
Department of Pharmacy, Tartous University
(01/09/2018 – 31/01/2024)
Samer graduated with a final grade of 72.2/100, having gained a solid foundation in pharmaceutical sciences and practical experience through his coursework and projects.

Experience

💊 Pharmacist
Ghadeer Pharmacy
(01/12/2020 – 19/08/2022)
Samer managed prescription processing, handled patient queries, ensured compliance with pharmacy regulations, and updated inventory information, showcasing his practical expertise in the pharmaceutical field.

🔬 Internship: Campaign Against Covid-19
(12/09/2020 – 12/05/2021)
In this role, Samer contributed to examinations and vaccinations, playing a crucial part in the fight against the pandemic.

🌍 Volunteering: UNICEF
(18/11/2013 – 20/11/2013)
Samer’s work with UNICEF included training and voluntary activities, reflecting his commitment to global health and community support.

Research Interests

Samer’s research interests lie in the intersection of nutrition and pharmacology, particularly focusing on the impact of micronutrients on health conditions and treatment outcomes. His work aims to advance understanding in these areas and contribute to more effective therapeutic strategies.

Awards and Certifications

Quality Advisor – Insight (Training Development & Consulting) (24/11/2022 – 28/11/2022)
Laboratory Work Level 1+2 – Insight (24/11/2022 – 28/11/2022)
Nutrition and Diets – Insight (02/02/2022 – 20/02/2022)
Nutrition Basics – Insight (12/12/2021 – 20/12/2021)

Publications Top Notes

The Role of Nutrition on the Treatment of Covid-19
Human Nutrition & Metabolism, 200255 (2024)
Cited by: 4
The Role of Micronutrients on the Treatment of Diabetes
Human Nutrition & Metabolism, 200238 (2024)
Cited by: 4
The Impact of Micronutrients on the Sense of Taste
Human Nutrition & Metabolism, 200231 (2023)
Cited by: 2
The Relationship Between Gender and Pharmacology
Current Research in Pharmacology and Drug Discovery, 100192 (2024)
Cited by: 1

Conclusion

Samer Younes exhibits many strengths that align well with the criteria for the “Best Researcher Award.” His academic qualifications, practical experience, and dedication to continuous learning and community service are commendable. To strengthen his candidacy, focusing on increasing his research publications, specializing in a specific area, and enhancing his professional network and visibility will be crucial. With his solid foundation and commitment to growth, Samer has the potential to make significant contributions to the field and be a strong contender for the award.